Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Clinical trial NCT01242488 · COMPLETED
Trial details
- NCT number
- NCT01242488
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-06-01
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.